2026-22339NoticeWallet

NIH Patent Deal Could Put Heart-Rhythm Treatment in One Company's Hands

Published Date: 11/2/2026

Notice

Summary

The National Institutes of Health plans to give AntaraCore Systems, Inc. an exclusive license to use new catheter technology that treats dangerous heart rhythm problems called ventricular arrhythmia. This means AntaraCore will have special rights to develop and sell this life-saving treatment. If you want to comment or apply for a license, you must do so by December 2, 2026.

Analyzed Economic Effects

4 provisions identified: 2 benefits, 1 costs, 1 mixed.

New Catheter Systems to Treat Ventricular Arrhythmia

The patent estates cover two inventions (VINTAGE and SCIRP) that provide a catheter-based system and a synchronous circumferential intramyocardial resynchronization and pacing system intended to enable electrophysiologists to access and treat arrhythmogenic intramural substrates located within the ventricular myocardial wall. The notice describes these inventions as addressing intramural substrates currently not systematized.

Possible Exclusive License to AntaraCore

The National Heart, Lung, and Blood Institute is contemplating granting AntaraCore Systems, Inc. an exclusive patent license to practice the listed inventions. The exclusive territory may be worldwide and is limited to the field of catheter-based intramyocardial ablation for treating ventricular arrhythmia in a human.

License Will Be Royalty-Bearing

The prospective exclusive patent license described in this notice will be royalty-bearing if granted. This means any company that obtains the license will be required to pay royalties to the Government under the license terms.

Deadline to Comment or Apply: December 2, 2026

If you want to submit written comments, objections, or a complete application for a license in the prospective field of use, the NHLBI must receive them by December 2, 2026. The notice states that timely-filed complete applications will be treated as objections to the contemplated exclusive license.

Personalized for You

How does this regulation affect your finances?

Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Key Dates

Published Date
Comments Due
11/2/2026
12/2/2026

Department and Agencies

Department
Independent Agency
Agency
Health and Human Services Department
National Institutes of Health
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register